Terbinafine (Lamisil) Market Report

Global Terbinafine (Lamisil) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：187
  • REPORT CODE：GMM774512
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Terbinafine (Lamisil) market report explains the definition, types, applications, major countries, and major players of the Terbinafine (Lamisil) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Nu Pharm

    • Smaart Pharmaceutticals

    • Jamp Pharma Corporation

    • Pharmel Inc

    • Mylan Pharmaceuticals

    • Sivem Pharmaceuticals

    • Codal Synto

    • Qingdao Jinfeng Pharmaceutical

    • Novartis Pharmaceuticals Corporation

    • Qd Pharmaceuticals

    • Apotex Corporation

    • TEVA

    • Auro Pharma Inc

    • Pfizer

    • Qilu Pharmaceutical

    • Gokul Pharma

    • Perrigo

    • PLIVA

    By Type:

    • Oral

    • External Use

    By End-User:

    • Fungal Infection Of The Skin And Mucous Membrane

    • Onychomycosis

    • Bronchial Asthma

    • Gynecological Anti-Infection Preparation

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Terbinafine (Lamisil) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Terbinafine (Lamisil) Outlook to 2028- Original Forecasts

    • 2.2 Terbinafine (Lamisil) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Terbinafine (Lamisil) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Terbinafine (Lamisil) Market- Recent Developments

    • 6.1 Terbinafine (Lamisil) Market News and Developments

    • 6.2 Terbinafine (Lamisil) Market Deals Landscape

    7 Terbinafine (Lamisil) Raw Materials and Cost Structure Analysis

    • 7.1 Terbinafine (Lamisil) Key Raw Materials

    • 7.2 Terbinafine (Lamisil) Price Trend of Key Raw Materials

    • 7.3 Terbinafine (Lamisil) Key Suppliers of Raw Materials

    • 7.4 Terbinafine (Lamisil) Market Concentration Rate of Raw Materials

    • 7.5 Terbinafine (Lamisil) Cost Structure Analysis

      • 7.5.1 Terbinafine (Lamisil) Raw Materials Analysis

      • 7.5.2 Terbinafine (Lamisil) Labor Cost Analysis

      • 7.5.3 Terbinafine (Lamisil) Manufacturing Expenses Analysis

    8 Global Terbinafine (Lamisil) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Terbinafine (Lamisil) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Terbinafine (Lamisil) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Terbinafine (Lamisil) Market Outlook by Types and Applications to 2022

    • 9.1 Global Terbinafine (Lamisil) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global External Use Consumption and Growth Rate (2017-2022)

    • 9.2 Global Terbinafine (Lamisil) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Fungal Infection Of The Skin And Mucous Membrane Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Onychomycosis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Bronchial Asthma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Gynecological Anti-Infection Preparation Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Terbinafine (Lamisil) Market Analysis and Outlook till 2022

    • 10.1 Global Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.2.2 Canada Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.2.3 Mexico Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.2 UK Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.3 Spain Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.4 Belgium Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.5 France Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.6 Italy Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.7 Denmark Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.8 Finland Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.9 Norway Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.10 Sweden Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.11 Poland Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.12 Russia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.3.13 Turkey Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.2 Japan Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.3 India Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.4 South Korea Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.5 Pakistan Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.6 Bangladesh Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.7 Indonesia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.8 Thailand Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.9 Singapore Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.10 Malaysia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.11 Philippines Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.4.12 Vietnam Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.2 Colombia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.3 Chile Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.4 Argentina Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.5 Venezuela Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.6 Peru Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.5.8 Ecuador Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.6.2 Kuwait Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.6.3 Oman Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.6.4 Qatar Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.7.2 South Africa Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.7.3 Egypt Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.7.4 Algeria Terbinafine (Lamisil) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Terbinafine (Lamisil) Consumption (2017-2022)

      • 10.8.2 New Zealand Terbinafine (Lamisil) Consumption (2017-2022)

    11 Global Terbinafine (Lamisil) Competitive Analysis

    • 11.1 Nu Pharm

      • 11.1.1 Nu Pharm Company Details

      • 11.1.2 Nu Pharm Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Nu Pharm Terbinafine (Lamisil) Main Business and Markets Served

      • 11.1.4 Nu Pharm Terbinafine (Lamisil) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Smaart Pharmaceutticals

      • 11.2.1 Smaart Pharmaceutticals Company Details

      • 11.2.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Main Business and Markets Served

      • 11.2.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Jamp Pharma Corporation

      • 11.3.1 Jamp Pharma Corporation Company Details

      • 11.3.2 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Jamp Pharma Corporation Terbinafine (Lamisil) Main Business and Markets Served

      • 11.3.4 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pharmel Inc

      • 11.4.1 Pharmel Inc Company Details

      • 11.4.2 Pharmel Inc Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pharmel Inc Terbinafine (Lamisil) Main Business and Markets Served

      • 11.4.4 Pharmel Inc Terbinafine (Lamisil) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Mylan Pharmaceuticals

      • 11.5.1 Mylan Pharmaceuticals Company Details

      • 11.5.2 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

      • 11.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sivem Pharmaceuticals

      • 11.6.1 Sivem Pharmaceuticals Company Details

      • 11.6.2 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

      • 11.6.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Codal Synto

      • 11.7.1 Codal Synto Company Details

      • 11.7.2 Codal Synto Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Codal Synto Terbinafine (Lamisil) Main Business and Markets Served

      • 11.7.4 Codal Synto Terbinafine (Lamisil) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Qingdao Jinfeng Pharmaceutical

      • 11.8.1 Qingdao Jinfeng Pharmaceutical Company Details

      • 11.8.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Main Business and Markets Served

      • 11.8.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Novartis Pharmaceuticals Corporation

      • 11.9.1 Novartis Pharmaceuticals Corporation Company Details

      • 11.9.2 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Main Business and Markets Served

      • 11.9.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Qd Pharmaceuticals

      • 11.10.1 Qd Pharmaceuticals Company Details

      • 11.10.2 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Qd Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

      • 11.10.4 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Apotex Corporation

      • 11.11.1 Apotex Corporation Company Details

      • 11.11.2 Apotex Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Apotex Corporation Terbinafine (Lamisil) Main Business and Markets Served

      • 11.11.4 Apotex Corporation Terbinafine (Lamisil) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 TEVA

      • 11.12.1 TEVA Company Details

      • 11.12.2 TEVA Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 TEVA Terbinafine (Lamisil) Main Business and Markets Served

      • 11.12.4 TEVA Terbinafine (Lamisil) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Auro Pharma Inc

      • 11.13.1 Auro Pharma Inc Company Details

      • 11.13.2 Auro Pharma Inc Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Auro Pharma Inc Terbinafine (Lamisil) Main Business and Markets Served

      • 11.13.4 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Pfizer

      • 11.14.1 Pfizer Company Details

      • 11.14.2 Pfizer Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Pfizer Terbinafine (Lamisil) Main Business and Markets Served

      • 11.14.4 Pfizer Terbinafine (Lamisil) Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Qilu Pharmaceutical

      • 11.15.1 Qilu Pharmaceutical Company Details

      • 11.15.2 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Qilu Pharmaceutical Terbinafine (Lamisil) Main Business and Markets Served

      • 11.15.4 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Gokul Pharma

      • 11.16.1 Gokul Pharma Company Details

      • 11.16.2 Gokul Pharma Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Gokul Pharma Terbinafine (Lamisil) Main Business and Markets Served

      • 11.16.4 Gokul Pharma Terbinafine (Lamisil) Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Perrigo

      • 11.17.1 Perrigo Company Details

      • 11.17.2 Perrigo Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Perrigo Terbinafine (Lamisil) Main Business and Markets Served

      • 11.17.4 Perrigo Terbinafine (Lamisil) Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 PLIVA

      • 11.18.1 PLIVA Company Details

      • 11.18.2 PLIVA Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 PLIVA Terbinafine (Lamisil) Main Business and Markets Served

      • 11.18.4 PLIVA Terbinafine (Lamisil) Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    12 Global Terbinafine (Lamisil) Market Outlook by Types and Applications to 2028

    • 12.1 Global Terbinafine (Lamisil) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global External Use Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Terbinafine (Lamisil) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Fungal Infection Of The Skin And Mucous Membrane Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Bronchial Asthma Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Gynecological Anti-Infection Preparation Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Terbinafine (Lamisil) Market Analysis and Outlook to 2028

    • 13.1 Global Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.2 UK Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.5 France Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.3 India Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Terbinafine (Lamisil) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Terbinafine (Lamisil) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Terbinafine (Lamisil)

    • Figure of Terbinafine (Lamisil) Picture

    • Table Global Terbinafine (Lamisil) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Terbinafine (Lamisil) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global External Use Consumption and Growth Rate (2017-2022)

    • Figure Global Fungal Infection Of The Skin And Mucous Membrane Consumption and Growth Rate (2017-2022)

    • Figure Global Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure Global Bronchial Asthma Consumption and Growth Rate (2017-2022)

    • Figure Global Gynecological Anti-Infection Preparation Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Table North America Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure United States Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Canada Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table Europe Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure Germany Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure UK Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Spain Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure France Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Italy Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Finland Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Norway Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Poland Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Russia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table APAC Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure China Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Japan Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure India Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table South America Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure Brazil Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Chile Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Peru Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table GCC Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure Bahrain Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Oman Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table Africa Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure Nigeria Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table Oceania Terbinafine (Lamisil) Consumption by Country (2017-2022)

    • Figure Australia Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Terbinafine (Lamisil) Consumption and Growth Rate (2017-2022)

    • Table Nu Pharm Company Details

    • Table Nu Pharm Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nu Pharm Terbinafine (Lamisil) Main Business and Markets Served

    • Table Nu Pharm Terbinafine (Lamisil) Product Portfolio

    • Table Smaart Pharmaceutticals Company Details

    • Table Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Smaart Pharmaceutticals Terbinafine (Lamisil) Main Business and Markets Served

    • Table Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolio

    • Table Jamp Pharma Corporation Company Details

    • Table Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jamp Pharma Corporation Terbinafine (Lamisil) Main Business and Markets Served

    • Table Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolio

    • Table Pharmel Inc Company Details

    • Table Pharmel Inc Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmel Inc Terbinafine (Lamisil) Main Business and Markets Served

    • Table Pharmel Inc Terbinafine (Lamisil) Product Portfolio

    • Table Mylan Pharmaceuticals Company Details

    • Table Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

    • Table Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

    • Table Sivem Pharmaceuticals Company Details

    • Table Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sivem Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

    • Table Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

    • Table Codal Synto Company Details

    • Table Codal Synto Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Codal Synto Terbinafine (Lamisil) Main Business and Markets Served

    • Table Codal Synto Terbinafine (Lamisil) Product Portfolio

    • Table Qingdao Jinfeng Pharmaceutical Company Details

    • Table Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Main Business and Markets Served

    • Table Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolio

    • Table Novartis Pharmaceuticals Corporation Company Details

    • Table Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Main Business and Markets Served

    • Table Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolio

    • Table Qd Pharmaceuticals Company Details

    • Table Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qd Pharmaceuticals Terbinafine (Lamisil) Main Business and Markets Served

    • Table Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolio

    • Table Apotex Corporation Company Details

    • Table Apotex Corporation Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Corporation Terbinafine (Lamisil) Main Business and Markets Served

    • Table Apotex Corporation Terbinafine (Lamisil) Product Portfolio

    • Table TEVA Company Details

    • Table TEVA Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Terbinafine (Lamisil) Main Business and Markets Served

    • Table TEVA Terbinafine (Lamisil) Product Portfolio

    • Table Auro Pharma Inc Company Details

    • Table Auro Pharma Inc Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Auro Pharma Inc Terbinafine (Lamisil) Main Business and Markets Served

    • Table Auro Pharma Inc Terbinafine (Lamisil) Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Terbinafine (Lamisil) Main Business and Markets Served

    • Table Pfizer Terbinafine (Lamisil) Product Portfolio

    • Table Qilu Pharmaceutical Company Details

    • Table Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Terbinafine (Lamisil) Main Business and Markets Served

    • Table Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolio

    • Table Gokul Pharma Company Details

    • Table Gokul Pharma Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gokul Pharma Terbinafine (Lamisil) Main Business and Markets Served

    • Table Gokul Pharma Terbinafine (Lamisil) Product Portfolio

    • Table Perrigo Company Details

    • Table Perrigo Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perrigo Terbinafine (Lamisil) Main Business and Markets Served

    • Table Perrigo Terbinafine (Lamisil) Product Portfolio

    • Table PLIVA Company Details

    • Table PLIVA Terbinafine (Lamisil) Sales, Price, Value and Gross Profit (2017-2022)

    • Table PLIVA Terbinafine (Lamisil) Main Business and Markets Served

    • Table PLIVA Terbinafine (Lamisil) Product Portfolio

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fungal Infection Of The Skin And Mucous Membrane Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bronchial Asthma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gynecological Anti-Infection Preparation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Table North America Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure United States Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure Germany Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure China Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Terbinafine (Lamisil) Consumption Forecast by Country (2022-2028)

    • Figure Australia Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Terbinafine (Lamisil) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US